Tag: Triple-negative Breast Cancer

Oncotarget News

Figure 2: Active pharmacological intervention trials in TNBC.

Crosstalk Between Triple Negative Breast Cancer and Microenvironment

April 10, 2023

the study of immunotherapy for treating triple negative breast cancer might still be at its early stages of development but is full of future promise.” BUFFALO, NY- April 10,... read more

Oncotarget

Behind the Study: Inhibition of Resistant Triple-negative Breast Cancer Cells

September 19, 2022

Dr. Balraj Singh from the University of Texas MD Anderson Cancer Center, describes a recent research paper he co-authored that was published by Oncotarget, entitled, “Inhibition of resistant triple-negative breast... read more